CN101284087B - Medicinal composition for curing lumbar disease - Google Patents
Medicinal composition for curing lumbar disease Download PDFInfo
- Publication number
- CN101284087B CN101284087B CN2008100182502A CN200810018250A CN101284087B CN 101284087 B CN101284087 B CN 101284087B CN 2008100182502 A CN2008100182502 A CN 2008100182502A CN 200810018250 A CN200810018250 A CN 200810018250A CN 101284087 B CN101284087 B CN 101284087B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- lumbar
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 5
- 239000000203 mixture Substances 0.000 title abstract description 5
- 201000010099 disease Diseases 0.000 title abstract description 4
- 239000004863 Frankincense Substances 0.000 claims abstract description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 9
- 241000218176 Corydalis Species 0.000 claims abstract description 8
- 241000725145 Homalomena Species 0.000 claims abstract description 8
- 241001522129 Pinellia Species 0.000 claims abstract description 8
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 8
- 206010041591 Spinal osteoarthritis Diseases 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 241000717739 Boswellia sacra Species 0.000 claims description 8
- 235000003301 Ceiba pentandra Nutrition 0.000 claims description 8
- 244000146553 Ceiba pentandra Species 0.000 claims description 8
- 241001489978 Eupolyphaga Species 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 241000283956 Manis Species 0.000 claims description 8
- 241001057584 Myrrha Species 0.000 claims description 8
- 241000237636 Pheretima Species 0.000 claims description 8
- 241000283690 Bos taurus Species 0.000 claims description 7
- 241000736199 Paeonia Species 0.000 claims description 7
- 241000522620 Scorpio Species 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 239000002398 materia medica Substances 0.000 claims description 7
- 239000009490 scorpio Substances 0.000 claims description 7
- 241000255791 Bombyx Species 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 3
- 210000000988 bone and bone Anatomy 0.000 abstract description 9
- 208000006820 Arthralgia Diseases 0.000 abstract description 5
- 206010024453 Ligament sprain Diseases 0.000 abstract description 5
- 206010050031 Muscle strain Diseases 0.000 abstract description 5
- 208000007103 Spondylolisthesis Diseases 0.000 abstract description 5
- 208000010040 Sprains and Strains Diseases 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 206010020718 hyperplasia Diseases 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 241000332382 Ceiba Species 0.000 abstract 1
- 240000000425 Chaenomeles speciosa Species 0.000 abstract 1
- 235000005078 Chaenomeles speciosa Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241001634536 Eriolaena Species 0.000 abstract 1
- 235000012097 Eugenia cumini Nutrition 0.000 abstract 1
- 244000060474 Eugenia jambolana Species 0.000 abstract 1
- 241000146384 Glaux Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 abstract 1
- 206010050296 Intervertebral disc protrusion Diseases 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 244000202052 Poncirus trifoliata Species 0.000 abstract 1
- 235000000404 Poncirus trifoliata Nutrition 0.000 abstract 1
- 235000017831 Pseudocydonia sinensis Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 241000316332 Scurrula Species 0.000 abstract 1
- 244000107975 Strychnos nux-vomica Species 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 210000003056 antler Anatomy 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 244000045947 parasite Species 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 description 8
- 206010005963 Bone formation increased Diseases 0.000 description 7
- 208000012287 Prolapse Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 241000202807 Glycyrrhiza Species 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 206010025005 lumbar spinal stenosis Diseases 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 208000005198 spinal stenosis Diseases 0.000 description 4
- 239000002775 capsule Substances 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001217 buttock Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002078 massotherapy Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000002385 vertebral artery Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a pharmaceutical composition for treating lumbar diseases. The composition contains milk vetch, cassia twig, peony, notopterygium root, Chinese Angelica, jambolan, pinellia tuber, Chinese quince, poria, trifoliate orange fruit, root of red rooted salvia, antler, ceiba, himalayan teasel root, cibot rhizome, Chinese milkwort, frankincense, myrrh, ground beetle, nux vomica, roasted pangolin, showy eriolaena bark, parasite scurrula, radix cyathulae, nutgrass galingale rhizome, corydalis tuber, liquorice, medlar, earthworm, homalomena rhizome, etc. Clinical tests prove that the composition is effective in treating lumbar intervertebral disc protrusion, lumbar hyperplasia, cervical vertebra hyperplasia, narrow lumbar canal, lumbar spondylolisthesis, lumbar muscle strain, fracture, bone sprain, traumatic arthralgia, etc., with good effect.
Description
Technical field
The invention belongs to technical field of Chinese medicines, relate to a kind of Chinese medicine composition, relate in particular to a kind of pharmaceutical composition for the treatment of lumbar spondylosis.
Background technology
Lumbar spondylosis is a kind of commonly encountered diseases, frequently-occurring disease.Mostly be prolapse of lumbar intervertebral disc clinically, prolapse of lumbar intervertebral disc be a kind of be that cardinal symptom, comparatively common spinal column are sick and wounded with waist, buttocks, skelalgia, and often control or malpractice because of early stage mistake, increase the weight of and cause intervertebral disc chondroclasis, vertebral pulp to give prominence to, cause serious waist buttocks skelalgia or lower limb sciatica, bring very big misery to the patient.
The treatment lumbar spondylosis has two kinds of operation and non-operations, and operative treatment only limits to the obvious spinal cord of fraction, nerve root and the impaired patient of vertebral artery, and most of lumbar spondylosis needs to treat by non-operative treatment.The traditional method of Chinese traditional treatment lumbar spondylosis is a massage therapy, and its course of treatment is long, and it is slow to take effect, and if be very dangerous with massage and rotation above neck, lumbar vertebra physiology dynamics scope.
Summary of the invention
The purpose of this invention is to provide a kind of pharmaceutical composition for the treatment of lumbar spondylosis.
Pharmaceutical composition of the present invention is prepared into acceptable preparation on the materia medica by following bulk drugs:
6~10 parts of 6~10 portions of Rhizoma Et Radix Notopterygiis of 6~10 portions of Radix Paeoniaes of 10~15 parts of Ramulus Cinnamomi of the Radix Astragali
Beg 8~13 parts of 5~8 parts of TIEJIAOLI of 6~10 parts of Rhizoma Pinelliaes of 10~15 parts of Oleum Linderae in vain
10~15 parts in 8~13 parts of Cornu Cervi Pantotrichums of 5~8 parts of Radix Salviae Miltiorrhizaes of 6~10 parts of Fructus Aurantiis of Poria
6~10 parts of 8~13 parts of Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) of 5~8 parts of Rhizoma Cibotii of 6~10 parts of Radix Dipsacis of kapok
8~13 parts bitter real 10~15 parts of 5~8 parts of eupolyphaga of 5~8 parts of Myrrhas of Olibanum
Process 0~5 part of 0~15 part of Scorpio of 0~10 part of Herba Taxilli of 10~15 parts of Cortex torricelliae tiliifoliaes of Squama Manis
0~10 part of 0~10 part of Bombyx Batryticatus of 0~10 part of Rhizoma Corydalis of river cattle sunset 6~10 portions of Rhizoma Cyperis
6~8 parts of 8~13 parts of Rhizoma Homalomenaes of 0~10 part of Pheretima of 1~6 portion of Fructus Lycii of Radix Glycyrrhizae.
In the aforementioned pharmaceutical compositions, Ramulus Cinnamomi, Radix Paeoniae, Radix Glycyrrhizae are with the sour and sweet drugs can transforme into YIN harmonizing yingfen and weifen; Rhizoma Cyperi, Rhizoma Corydalis, eupolyphaga, Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae), Radix Salviae Miltiorrhizae is begged, Oleum Linderae in vain, and Radix Dipsaci is with circulation of qi promoting, promoting the circulation of blood, blood circulation promoting and blood stasis dispelling; The Rhizoma Et Radix Notopterygii dehumidifying is induced sweat; Cortex torricelliae tiliifoliae, Scorpio, Bombyx Batryticatus, TIEJIAOLI, Olibanum, Myrrha, river Niu Xi, Pheretima are with channels sootheing and network vessel quickening; The Rhizoma Pinelliae, Poria, Fructus Aurantii eliminating phlegm and removing dampness; The Radix Astragali, kapok, Rhizoma Cibotii, Cornu Cervi Pantotrichum, Rhizoma Homalomenae, Herba Taxilli, Fructus Lycii are to transfer tonifying kidney-yin, and be vigorous to reach QI and blood; Bitter real, process Squama Manis with hard masses softening and resolving, detumescence.
The function of medicine of the present invention: blood circulation promoting and blood stasis dispelling, channels sootheing and network vessel quickening, invigorating the liver and kidney, expelling wind and removing dampness.
Cure mainly: prolapse of lumbar intervertebral disc, hyperosteogeny, hyperosteogeny, lumbar spinal stenosis, lumbar spondylolisthesis, lumbar muscle strain, fracture, bone sprain, wound sequela and wound bone joint pain for a long time.
The effect of traditional Chinese medicine composition for treating lumbar spondylosis of the present invention can be illustrated by following clinical trial:
1, case is selected: prolapse of lumbar intervertebral disc patient's 50 examples, hyperosteogeny patient 120 examples, hyperosteogeny patient 50 examples, lumbar spinal stenosis 40 examples, lumbar spondylolisthesis 90 examples, lumbar muscle strain 60 examples, fracture, bone sprain patient 50, wound sequela and wound bone joint pain 20 examples for a long time.
2, Therapeutic Method: powder, one time 3 gram, 2 times on the one, course of treatment of two weeks, one to two course of treatment of state of an illness the lighter, the heavier person of the state of an illness needs three to four courses of treatment.
3, curative effect is calmed down standard
3.1 recovery from illness: Signs recovers normal, follows up a case by regular visits to and does not have repeatedly in 3 months.
3.2 produce effects: Signs obviously has improvement, and slight illness obviously alleviates.
3.3 effectively: Signs makes moderate progress can operate as normal.
3.4 invalid: Signs is without any improvement.
4, therapeutic outcome:
4.1 prolapse of lumbar intervertebral disc patient
Prolapse of lumbar intervertebral disc patient's 50 examples, wherein cure rate 72%, and obvious effective rate 18% is effective 8%, inefficiency 2%.
4.2 hyperosteogeny patient
Hyperosteogeny patient 120 examples, wherein cure rate 84%, and obvious effective rate 12% is effective 4%, inefficiency 0%.
4.3 lumbar spinal stenosis
Lumbar spinal stenosis patient 40 examples, wherein cure rate 62%, and obvious effective rate 28% is effective 8%, inefficiency 2%.
4.4 lumbar spondylolisthesis
Lumbar spondylolisthesis 90 examples, wherein cure rate 78%, and obvious effective rate 18% is effective 4%, inefficiency 0%.
4.5 lumbar muscle strain
Lumbar muscle strain 60 examples, wherein cure rate 92%, and obvious effective rate 6% is effective 2%, inefficiency 0%.
4.6 fracture, bone sprain patient
Fracture, bone sprain patient 50, wherein cure rate 68%, and obvious effective rate 28% is effective 4%, inefficiency 0%.
4.7 long wound sequela and wound bone joint pain patient.
For a long time wound sequela and wound bone joint pain 20 examples, wherein cure rate 14%, and obvious effective rate 42% is effective 32%, inefficiency 12%.
Clinical observation finds that also medicine of the present invention has good therapeutic effect to the hyperosteogeny disease.
The specific embodiment
The preparation of embodiment 1, capsule
Prescription: by weight
6 parts of 6 portions of Rhizoma Et Radix Notopterygiis of 6 portions of Radix Paeoniaes of 10 parts of Ramulus Cinnamomi of the Radix Astragali
Beg 8 parts of 5 parts of TIEJIAOLI of 6 parts of Rhizoma Pinelliaes of 10 parts of Oleum Linderae in vain
10 parts in 8 parts of Cornu Cervi Pantotrichums of 5 parts of Radix Salviae Miltiorrhizaes of 6 parts of Fructus Aurantiis of Poria
6 parts of 8 parts of Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) of 5 parts of Rhizoma Cibotii of 6 parts of Radix Dipsacis of kapok
8 parts bitter real 10 parts of 5 parts of eupolyphaga of 5 parts of Myrrhas of Olibanum
Process 3 parts of 5 parts of Scorpio of 3 parts of Herba Taxillis of 10 parts of Cortex torricelliae tiliifoliaes of Squama Manis
5 parts of 5 parts of Bombyx Batryticatus of 8 parts of Rhizoma Corydalis of river cattle sunset 6 portions of Rhizoma Cyperis
6 parts of 8 parts of Rhizoma Homalomenaes of 7 parts of Pheretimas of 3 portions of Fructus Lyciis of Radix Glycyrrhizae.
Technology: the conventional adjuvant for preparing capsule by pharmacy of Chinese materia medica becomes capsule with prepared.
The preparation of embodiment 2, powder
Prescription: by weight
10 parts of 10 portions of Rhizoma Et Radix Notopterygiis of 10 portions of Radix Paeoniaes of 15 parts of Ramulus Cinnamomi of the Radix Astragali
Beg 13 parts of 8 parts of TIEJIAOLI of 10 parts of Rhizoma Pinelliaes of 15 parts of Oleum Linderae in vain
15 parts in 10 parts of Cornu Cervi Pantotrichums of 8 parts of Radix Salviae Miltiorrhizaes of 10 parts of Fructus Aurantiis of Poria
10 parts of 13 parts of Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) of 6 parts of Rhizoma Cibotii of 10 parts of Radix Dipsacis of kapok
13 parts bitter real 15 parts of 8 parts of eupolyphaga of 8 parts of Myrrhas of Olibanum
Process 10 parts of 0~15 part of Scorpio of 15 parts of Herba Taxillis of Squama Manis, 5 parts of river cattle sunset
1~6 part in 5 portions of Radix Glycyrrhizaes of 5 parts of Bombyx Batryticatus of 10 parts of Rhizoma Corydalis of Rhizoma Cyperi
8 parts of 10 parts of Rhizoma Homalomenaes of 8 parts of Pheretimas of Fructus Lycii.
Technology: the common process for preparing powder by pharmacy of Chinese materia medica is prepared into powder.
The preparation of embodiment 3, electuary
Prescription: by weight
8 parts of 8 portions of Rhizoma Et Radix Notopterygiis of 8 portions of Radix Paeoniaes of 10 parts of Ramulus Cinnamomi of the Radix Astragali
Beg 8 parts of 8 parts of TIEJIAOLI of 10 parts of Rhizoma Pinelliaes of 12 parts of Oleum Linderae in vain
12 parts in 8 parts of Cornu Cervi Pantotrichums of 5 parts of Radix Salviae Miltiorrhizaes of 8 parts of Fructus Aurantiis of Poria
6 parts of 8 parts of Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) of 8 parts of Rhizoma Cibotii of 8 parts of Radix Dipsacis of kapok
8 parts bitter real 12 parts of 8 parts of eupolyphaga of 8 parts of Myrrhas of Olibanum
Process 2 parts of river cattle sunset of 12 parts of Scorpio of Squama Manis, 8 parts of 8 portions of Rhizoma Cyperis
8 parts of 6 portions of Fructus Lyciis of 8 portions of Radix Glycyrrhizaes of 8 parts of Bombyx Batryticatus of Rhizoma Corydalis
8 parts of 8 parts of Rhizoma Homalomenaes of Pheretima.
Technology: the conventional adjuvant for preparing electuary by pharmacy of Chinese materia medica becomes electuary with prepared.
The preparation of embodiment 4, pill
Prescription: by weight
8 parts of 8 portions of Rhizoma Et Radix Notopterygiis of 8 portions of Radix Paeoniaes of 12 parts of Ramulus Cinnamomi of the Radix Astragali
Beg 10 parts of 8 parts of TIEJIAOLI of 10 parts of Rhizoma Pinelliaes of 12 parts of Oleum Linderae in vain
12 parts in 8 parts of Cornu Cervi Pantotrichums of 8 parts of Radix Salviae Miltiorrhizaes of 10 parts of Fructus Aurantiis of Poria
10 parts of 13 parts of Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) of 8 parts of Rhizoma Cibotii of 10 parts of Radix Dipsacis of kapok
8 parts bitter real 10 parts of 5 parts of eupolyphaga of 5 parts of Myrrhas of Olibanum
Process 10 parts of 5 parts of Pheretimas of Squama Manis 10 parts of river cattle sunset, 8 portions of Radix Glycyrrhizaes
6 parts of Rhizoma Homalomenaes.
Technology: the conventional adjuvant for preparing pill by pharmacy of Chinese materia medica becomes pill with prepared.
The preparation of embodiment 5, tablet
Prescription: by weight
60 parts of 6 portions of Rhizoma Et Radix Notopterygiis of 6 portions of Radix Paeoniaes of 10 parts of Ramulus Cinnamomi of the Radix Astragali
Beg 8 parts of 5 parts of TIEJIAOLI of 10 parts of Rhizoma Pinelliaes of 15 parts of Oleum Linderae in vain
10 parts in 13 parts of Cornu Cervi Pantotrichums of 8 parts of Radix Salviae Miltiorrhizaes of 10 parts of Fructus Aurantiis of Poria
6 parts of 8 parts of Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) of 5 parts of Rhizoma Cibotii of 6 parts of Radix Dipsacis of kapok
13 parts bitter real 10 parts of 8 parts of eupolyphaga of 8 parts of Myrrhas of Olibanum
Process 10 parts of 3 parts of Scorpio of 10 parts of Cortex torricelliae tiliifoliaes of Squama Manis, 4 parts of river cattle sunset
5 parts of 6 portions of Fructus Lyciis of 8 portions of Radix Glycyrrhizaes of 8 parts of Rhizoma Corydalis of Rhizoma Cyperi
8 parts of 10 parts of Rhizoma Homalomenaes of Pheretima.
Technology: the conventional adjuvant for preparing tablet by pharmacy of Chinese materia medica becomes tablet with prepared.
Claims (2)
1. pharmaceutical composition for the treatment of lumbar spondylosis is prepared from by following bulk drugs:
6~10 parts of 6~10 portions of Rhizoma Et Radix Notopterygiis of 6~10 portions of Radix Paeoniaes of 10~15 parts of Ramulus Cinnamomi of the Radix Astragali
Beg 8~13 parts of 5~8 parts of TIEJIAOLI of 6~10 parts of Rhizoma Pinelliaes of 10~15 parts of Oleum Linderae in vain
10~15 parts in 8~13 parts of Cornu Cervi Pantotrichums of 5~8 parts of Radix Salviae Miltiorrhizaes of 6~10 parts of Fructus Aurantiis of Poria
6~10 parts of 8~13 parts of Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) of 5~8 parts of Rhizoma Cibotii of 6~10 parts of Radix Dipsacis of kapok
8~13 parts bitter real 10~15 parts of 5~8 parts of eupolyphaga of 5~8 parts of Myrrhas of Olibanum
Process 0~5 part of 0~15 part of Scorpio of 0~10 part of Herba Taxilli of 10~15 parts of Cortex torricelliae tiliifoliaes of Squama Manis
0~10 part of 0~10 part of Bombyx Batryticatus of 0~10 part of Rhizoma Corydalis of river cattle sunset 6~10 portions of Rhizoma Cyperis
6~8 parts of 8~13 parts of Rhizoma Homalomenaes of 0~10 part of Pheretima of 1~6 portion of Fructus Lycii of Radix Glycyrrhizae.
2. treat the pharmaceutical composition of lumbar spondylosis according to claim 1, it is characterized in that: adopt the common process and the adjuvant of pharmaceutics, be prepared into acceptable preparation on the materia medica.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100182502A CN101284087B (en) | 2008-05-09 | 2008-05-09 | Medicinal composition for curing lumbar disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100182502A CN101284087B (en) | 2008-05-09 | 2008-05-09 | Medicinal composition for curing lumbar disease |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101284087A CN101284087A (en) | 2008-10-15 |
CN101284087B true CN101284087B (en) | 2010-12-22 |
Family
ID=40056641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100182502A Expired - Fee Related CN101284087B (en) | 2008-05-09 | 2008-05-09 | Medicinal composition for curing lumbar disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101284087B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103007036B (en) * | 2012-12-28 | 2014-02-26 | 葛风晓 | Chinese herba preparation for treating vertebral compression fractures |
CN107184648A (en) * | 2017-06-02 | 2017-09-22 | 广州智润生物制药科技有限公司 | It is a kind of to treat patch of protrusion of lumber intervertebral disc and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1335162A (en) * | 2001-08-09 | 2002-02-13 | 杨双喜 | Medicine for treating protrusion of cervical and lumbar intervertebral disc |
CN1554416A (en) * | 2003-12-22 | 2004-12-15 | 高化育 | Chinese medicine decoction recipe fortreating prolapse of lumber intercertebtral disc |
-
2008
- 2008-05-09 CN CN2008100182502A patent/CN101284087B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1335162A (en) * | 2001-08-09 | 2002-02-13 | 杨双喜 | Medicine for treating protrusion of cervical and lumbar intervertebral disc |
CN1554416A (en) * | 2003-12-22 | 2004-12-15 | 高化育 | Chinese medicine decoction recipe fortreating prolapse of lumber intercertebtral disc |
Also Published As
Publication number | Publication date |
---|---|
CN101284087A (en) | 2008-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100402066C (en) | Plaster for treating rheumatism and osteoarthrosis | |
CN100361704C (en) | Medicated wine for treating rheumatosis and osteoarthropathy | |
CN101095845A (en) | Century health preserving magical wine | |
CN101485836A (en) | Oral capsule for treating neck, waist and leg pain diseases and preparation method thereof | |
CN103006951B (en) | Chinese medicinal composition for treating cervical spondylosis and lumbar spondylosis | |
CN101766775A (en) | Medicine for treating lumbar disc herniation and osteoproliferation | |
CN102283921A (en) | Prescription drug for curing jugular and lumbar herniated disk | |
CN1970045B (en) | Externally applied Chinese medicine for treating cervical and lumbar spondylosis | |
CN102048900A (en) | Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion | |
CN101658657B (en) | Drug for treating chronic cholecystitis | |
CN101112537A (en) | Chinese traditional medicine preparations for treating hyperosteogeny disease | |
CN103316141A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
CN104013769A (en) | Traditional Chinese medicine oral solution for treating osteoporosis | |
CN104000933A (en) | Traditional Chinese medicine oral liquid for treating osteoproliferation | |
CN101284087B (en) | Medicinal composition for curing lumbar disease | |
CN103316296B (en) | Traditional Chinese medicine composition for treating hyperostosis | |
CN1079029C (en) | Medical capsule for treating bone rheumatism and preparing process | |
CN104383166A (en) | Medicine for treating rheumatic lumbocrural pains and preparation method thereof | |
CN100542583C (en) | A kind of pharmaceutical composition for treating spinal and joint diseases | |
CN103800840A (en) | Oral traditional Chinese medicine solution for treating cervical spondylosis | |
CN103784824A (en) | Chinese herbal preparation for treating lumbar disc herniation and rheumatoid | |
CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
CN1129439C (en) | Hyperosteogeny-treating capsule | |
CN102579672A (en) | Medicament for treating bone hyperplasia and lumbar disc herniation | |
CN102406870A (en) | Medicine for treating rheumatic arthralgia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101222 Termination date: 20170509 |